IL263292A - Protease-resistant mono-lipidated peptides - Google Patents
Protease-resistant mono-lipidated peptidesInfo
- Publication number
- IL263292A IL263292A IL263292A IL26329218A IL263292A IL 263292 A IL263292 A IL 263292A IL 263292 A IL263292 A IL 263292A IL 26329218 A IL26329218 A IL 26329218A IL 263292 A IL263292 A IL 263292A
- Authority
- IL
- Israel
- Prior art keywords
- protease
- lipidated peptides
- mono
- resistant mono
- resistant
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title 1
- 239000004365 Protease Substances 0.000 title 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662347693P | 2016-06-09 | 2016-06-09 | |
| PCT/EP2017/063905 WO2017211922A2 (en) | 2016-06-09 | 2017-06-08 | Protease-resistant mono-lipidated peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL263292A true IL263292A (en) | 2018-12-31 |
Family
ID=59078034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL263292A IL263292A (en) | 2016-06-09 | 2018-11-26 | Protease-resistant mono-lipidated peptides |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3468987A2 (de) |
| JP (1) | JP2019525732A (de) |
| KR (1) | KR20190017017A (de) |
| CN (1) | CN109195984A (de) |
| AU (1) | AU2017277594A1 (de) |
| BR (1) | BR112018072968A2 (de) |
| CA (1) | CA3025592A1 (de) |
| IL (1) | IL263292A (de) |
| MX (1) | MX2018014966A (de) |
| WO (1) | WO2017211922A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3684793A1 (de) * | 2017-09-22 | 2020-07-29 | Regeneron Pharmaceuticals, Inc. | Glucagon-ähnliche peptid-1-rezeptor-agonisten und verwendungen davon |
| MX2020010505A (es) | 2018-04-05 | 2021-01-15 | Sun Pharmaceutical Ind Ltd | Analogos novedosos de glp-1. |
| US12084485B2 (en) * | 2020-12-17 | 2024-09-10 | I2O Therapeutics, Inc. | Long acting glucagon like polypeptide-1 (GLP-1) receptor agonists and methods of use |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| TW202346323A (zh) * | 2022-02-07 | 2023-12-01 | 英商梅迪繆思有限公司 | 具有改善的生物穩定性的ｇｌｐ—１及升糖素雙重激動肽 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008023050A1 (en) * | 2006-08-25 | 2008-02-28 | Novo Nordisk A/S | Acylated exendin-4 compounds |
| CN105849123A (zh) | 2013-12-13 | 2016-08-10 | 免疫医疗有限公司 | 蛋白酶抗性肽 |
| TWI726889B (zh) * | 2015-06-10 | 2021-05-11 | 英商梅迪繆思有限公司 | 蛋白酶抗性之脂化肽 |
-
2017
- 2017-06-08 MX MX2018014966A patent/MX2018014966A/es unknown
- 2017-06-08 KR KR1020197000408A patent/KR20190017017A/ko not_active Withdrawn
- 2017-06-08 WO PCT/EP2017/063905 patent/WO2017211922A2/en not_active Ceased
- 2017-06-08 AU AU2017277594A patent/AU2017277594A1/en not_active Abandoned
- 2017-06-08 JP JP2018562568A patent/JP2019525732A/ja active Pending
- 2017-06-08 CN CN201780032425.2A patent/CN109195984A/zh active Pending
- 2017-06-08 EP EP17731089.3A patent/EP3468987A2/de not_active Withdrawn
- 2017-06-08 BR BR112018072968-0A patent/BR112018072968A2/pt not_active Application Discontinuation
- 2017-06-08 CA CA3025592A patent/CA3025592A1/en not_active Abandoned
-
2018
- 2018-11-26 IL IL263292A patent/IL263292A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3025592A1 (en) | 2017-12-14 |
| AU2017277594A1 (en) | 2019-02-07 |
| WO2017211922A2 (en) | 2017-12-14 |
| JP2019525732A (ja) | 2019-09-12 |
| WO2017211922A3 (en) | 2018-01-18 |
| MX2018014966A (es) | 2019-08-14 |
| CN109195984A (zh) | 2019-01-11 |
| EP3468987A2 (de) | 2019-04-17 |
| BR112018072968A2 (pt) | 2019-02-19 |
| KR20190017017A (ko) | 2019-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275298B1 (en) | Mitochondria-targeted peptides | |
| IL263292A (en) | Protease-resistant mono-lipidated peptides | |
| GB201520583D0 (en) | Peptides | |
| GB201607534D0 (en) | Peptides | |
| GB201520539D0 (en) | Peptides | |
| GB201612150D0 (en) | Modified peptide | |
| GB201604468D0 (en) | Peptides | |
| GB201520536D0 (en) | Peptides | |
| GB201520543D0 (en) | Peptides | |
| GB201520546D0 (en) | Peptides | |
| GB201520545D0 (en) | Peptides | |
| GB201520544D0 (en) | Peptides | |
| GB201520550D0 (en) | Peptides | |
| GB201520541D0 (en) | Peptides | |
| GB201607535D0 (en) | Peptides | |
| GB201520557D0 (en) | Peptides | |
| GB201520542D0 (en) | Peptides | |
| GB201520548D0 (en) | Peptides | |
| GB201719520D0 (en) | Neuroprotectvie peptide | |
| GB201620963D0 (en) | Antimicrobial peptides | |
| GB201518700D0 (en) | Peptides | |
| GB201715378D0 (en) | Peptides | |
| GB201715379D0 (en) | Peptides | |
| GB201711620D0 (en) | Peptides | |
| GB201707837D0 (en) | Peptides |